Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Before vs After Surgery for Stage II/III Esophageal Squamous Cell Carcinoma
NCT00190554Phase 3Terminated
- Sponsor
- Japan Clinical Oncology Group
- Start
- May 2000
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin and fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms), sponsored by Japan Clinical Oncology Group. Primary endpoint: Disease free survival. Started May 2000; status: terminated.
02
Drugs
cisplatinfluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT00190554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190554.